DK0969843T3 - Antitussive formuleringer indeholdende theobromin - Google Patents

Antitussive formuleringer indeholdende theobromin

Info

Publication number
DK0969843T3
DK0969843T3 DK98912636T DK98912636T DK0969843T3 DK 0969843 T3 DK0969843 T3 DK 0969843T3 DK 98912636 T DK98912636 T DK 98912636T DK 98912636 T DK98912636 T DK 98912636T DK 0969843 T3 DK0969843 T3 DK 0969843T3
Authority
DK
Denmark
Prior art keywords
theobromine
formulations containing
admixture
additives
salts
Prior art date
Application number
DK98912636T
Other languages
Danish (da)
English (en)
Inventor
Dezso Korbonits
Peter Aranyi
Endre Mikus
Istvan Jelinek
Original Assignee
Dezso Korbonits
Peter Aranyi
Endre Mikus
Istvan Jelinek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dezso Korbonits, Peter Aranyi, Endre Mikus, Istvan Jelinek filed Critical Dezso Korbonits
Application granted granted Critical
Publication of DK0969843T3 publication Critical patent/DK0969843T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
DK98912636T 1997-03-26 1998-03-20 Antitussive formuleringer indeholdende theobromin DK0969843T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700654A HUP9700654A2 (hu) 1997-03-26 1997-03-26 Teobromin tartalmú köhögéscsillapító készítmények
PCT/HU1998/000027 WO1998042322A2 (fr) 1997-03-26 1998-03-20 Compositions antitussives

Publications (1)

Publication Number Publication Date
DK0969843T3 true DK0969843T3 (da) 2002-10-07

Family

ID=89994918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98912636T DK0969843T3 (da) 1997-03-26 1998-03-20 Antitussive formuleringer indeholdende theobromin

Country Status (23)

Country Link
US (1) US6348470B1 (fr)
EP (1) EP0969843B1 (fr)
JP (1) JP4450872B2 (fr)
KR (1) KR100420370B1 (fr)
CN (1) CN1251039A (fr)
AT (1) ATE218868T1 (fr)
AU (1) AU6741498A (fr)
BG (1) BG103780A (fr)
BR (1) BR9809057A (fr)
CA (1) CA2284774C (fr)
CZ (1) CZ295801B6 (fr)
DE (1) DE69805983T2 (fr)
DK (1) DK0969843T3 (fr)
EA (1) EA001971B1 (fr)
EE (1) EE9900428A (fr)
ES (1) ES2178188T3 (fr)
HU (1) HUP9700654A2 (fr)
IL (2) IL131811A0 (fr)
NO (1) NO994640L (fr)
PL (1) PL190899B1 (fr)
PT (1) PT969843E (fr)
SK (1) SK285023B6 (fr)
WO (1) WO1998042322A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030032484A (ko) * 2001-10-18 2003-04-26 롯데제과주식회사 발암 억제효능을 갖는 데오브로민
JP2004018512A (ja) * 2002-06-20 2004-01-22 Morinaga & Co Ltd 冷え性改善用組成物および冷え性改善用組成物の製造のためのカカオ豆加工物の使用
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
US20150216869A1 (en) * 2009-06-16 2015-08-06 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
US20150005325A1 (en) * 2009-06-16 2015-01-01 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
GB201014391D0 (en) 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0921803D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0919889D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0921805D0 (en) * 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
AU2015201845B2 (en) * 2009-11-13 2015-11-05 Infirst Healthcare Limited Drug combination with theobromine and its use in therapy
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
NL1040474C2 (en) 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
KR20160126217A (ko) 2015-04-23 2016-11-02 주식회사 진명 에프 엠 씨 용기 투입장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1113122B (it) * 1978-04-06 1986-01-20 Abc Ist Biolog Chem Spa Composizione farmaceutica ad attivita' antibrocospastica e antitosse
FR2531339A1 (fr) * 1982-08-04 1984-02-10 Dietlin Francois Nouveau procede d'obtention de formes pharmaceutiques a liberation programmee
HU197574B (en) 1986-10-09 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of derivatives of 3,7-dihydro-3-methil-7-//1,2,4-oxadiasole/-3-il/alkylenil/-1h-purin-2,6-dion and medical compositions containing these substances
GB2201591B (en) * 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
BR9407414A (pt) * 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
CA2227958A1 (fr) * 1995-07-28 1997-02-13 Sekhar Mitra Compositions contenant des analgesiques et des antihistaminiques et procedes de traitement d'affections respiratoires

Also Published As

Publication number Publication date
ES2178188T3 (es) 2002-12-16
HUP9700654A2 (hu) 1999-09-28
EE9900428A (et) 2000-04-17
KR100420370B1 (ko) 2004-03-03
SK127399A3 (en) 2000-09-12
JP2001518928A (ja) 2001-10-16
IL131811A0 (en) 2001-03-19
WO1998042322A2 (fr) 1998-10-01
AU6741498A (en) 1998-10-20
IL131811A (en) 2006-06-11
CA2284774C (fr) 2005-12-06
NO994640D0 (no) 1999-09-24
BR9809057A (pt) 2000-08-01
CZ295801B6 (cs) 2005-11-16
JP4450872B2 (ja) 2010-04-14
EA001971B1 (ru) 2001-10-22
KR20010005642A (ko) 2001-01-15
BG103780A (en) 2001-04-30
PT969843E (pt) 2002-10-31
EP0969843A2 (fr) 2000-01-12
DE69805983T2 (de) 2003-01-30
CA2284774A1 (fr) 1998-10-01
CZ339199A3 (cs) 2000-04-12
EA199900876A1 (ru) 2000-04-24
EP0969843B1 (fr) 2002-06-12
PL335979A1 (en) 2000-06-05
CN1251039A (zh) 2000-04-19
US6348470B1 (en) 2002-02-19
ATE218868T1 (de) 2002-06-15
DE69805983D1 (de) 2002-07-18
SK285023B6 (sk) 2006-04-06
WO1998042322A3 (fr) 1998-12-17
HU9700654D0 (en) 1997-05-28
NO994640L (no) 1999-09-24
PL190899B1 (pl) 2006-02-28

Similar Documents

Publication Publication Date Title
DK0969843T3 (da) Antitussive formuleringer indeholdende theobromin
SE8503664D0 (sv) Drug delivery system
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
AU7023987A (en) Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
US5853768A (en) Topical preparation and method for pain relief
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
DE69102174D1 (de) Iontophoresezusammensetzung zur Erhöhung der Hautkonzentration aktiver Wirkstoffe.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
ATE164766T1 (de) Zusammensetzung aus asphodelus zur erhöhung der anzahl weisser blutzellen